Patents by Inventor Hitesh Jayantilal Sanganee

Hitesh Jayantilal Sanganee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MPO inhibitors for use in medicine
    Patent number: 11738027
    Abstract: The present disclosure relates to new therapeutic uses of MPO inhibitors and methods of treatment involving the same.
    Type: Grant
    Filed: December 2, 2021
    Date of Patent: August 29, 2023
    Assignee: AstraZeneca AB
    Inventors: Andrew Whittaker, Hitesh Jayantilal Sanganee
  • MPO INHIBITORS FOR USE IN MEDICINE
    Publication number: 20220160715
    Abstract: The present disclosure relates to new therapeutic uses of MPO inhibitors and methods of treatment involving the same.
    Type: Application
    Filed: December 2, 2021
    Publication date: May 26, 2022
    Inventors: Andrew WHITTAKER, Hitesh Jayantilal SANGANEE
  • MPO inhibitors for use in medicine
    Patent number: 11246870
    Abstract: The present disclosure relates to new therapeutic uses of MPO inhibitors and methods of treatment involving the same.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: February 15, 2022
    Assignee: ASTRAZENCA AB
    Inventors: Andrew Whittaker, Hitesh Jayantilal Sanganee
  • MPO INHIBITORS FOR USE IN MEDICINE
    Publication number: 20200206226
    Abstract: The present disclosure relates to new therapeutic uses of MPO inhibitors and methods of treatment involving the same.
    Type: Application
    Filed: July 12, 2018
    Publication date: July 2, 2020
    Inventors: Andrew WHITTAKER, Hitesh Jayantilal SANGANEE
  • PYRAZINE DERIVATIVES
    Publication number: 20130123275
    Abstract: The invention concerns pyrazine derivatives of the Formula I or pharmaceutically-acceptable salts thereof; wherein each of n, m and R has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of bone-related disorders or conditions.
    Type: Application
    Filed: May 7, 2012
    Publication date: May 16, 2013
    Applicant: ASTRAZENECA AB
    Inventors: Tao FENG, Hitesh Jayantilal SANGANEE, Hiroki WADA
  • Phenoxypyridinylamide compounds
    Patent number: 8273774
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    Type: Grant
    Filed: May 26, 2009
    Date of Patent: September 25, 2012
    Assignee: AstraZeneca AB
    Inventors: Glen Andrews, Rhona Jane Cox, Christopher De Savi, Premji Meghani, Hitesh Jayantilal Sanganee, Daniel Jon Warner
  • Pyrazine derivatives
    Patent number: 8198285
    Abstract: The invention concerns pyrazine derivatives of the Formula I or pharmaceutically-acceptable salts thereof; wherein each of n, m and R has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of bone-related disorders or conditions.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: June 12, 2012
    Assignee: Astrazeneca AB
    Inventors: Tao Feng, Hitesh Jayantilal Sanganee, Hiroki Wada
  • Chemical Compounds 637
    Publication number: 20120077801
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    Type: Application
    Filed: August 3, 2011
    Publication date: March 29, 2012
    Inventors: Roger Victor Bonnert, Rhona Jane Cox, Simon De Sousa, Mark Dickinson, Simon Fraser Hunt, Austen Pimm, Hitesh Jayantilal Sanganee, Frank Burkamp, Premji Meghani
  • PYRAZINE DERIVATIVES
    Publication number: 20120022082
    Abstract: The invention concerns pyrazine derivatives of the Formula I or pharmaceutically-acceptable salts thereof; wherein each of n, m and R has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of bone-related disorders or conditions.
    Type: Application
    Filed: January 18, 2011
    Publication date: January 26, 2012
    Applicant: ASTRAZENECA AB
    Inventors: Tao FENG, Hitesh Jayantilal SANGANEE, Hiroki WADA
  • Novel Compounds 010
    Publication number: 20110201581
    Abstract: The present invention provides compounds of formula (I) in which n, y, X1, X2, A, B, R1, R2, R3, R4 and R5 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: February 11, 2011
    Publication date: August 18, 2011
    Inventors: Mark Furber, Christopher Andrew Luckhurst, Hitesh Jayantilal Sanganee, Linda Anne Stein, Peter Alan Cage
  • Compounds 010
    Patent number: 7902181
    Abstract: The present invention provides compounds of formula (I) in which n, y, X1, X2, A, B, R1, R2, R3, R4 and R5 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: March 8, 2011
    Assignee: AstraZeneca AB
    Inventors: Mark Furber, Christopher Andrew Luckhurst, Hitesh Jayantilal Sanganee, Linda Anne Stein, Peter Alan Cage
  • Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
    Publication number: 20100204203
    Abstract: The present invention provides a compound of a formula (I), wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    Type: Application
    Filed: January 10, 2008
    Publication date: August 12, 2010
    Inventors: Roger Victor Bonnert, Frank Burkamp, Rhona Jane Cox, Simon de Sousa, Mark Dickinson, Simon Fraser Hunt, Premji Meghani, Austen Pimm, Hitesh Jayantilal Sanganee
  • Chemical Compounds 293
    Publication number: 20100041638
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    Type: Application
    Filed: May 26, 2009
    Publication date: February 18, 2010
    Inventors: Glen Andrews, Rhona Jane Cox, Christopher De Savi, Premji Meghani, Hitesh Jayantilal Sanganee, Daniel Jon Warner
  • Novel Compounds 010
    Publication number: 20090306042
    Abstract: The present invention provides compounds of formula (I) in which n, y, X1, X2, A, B, R1, R2, R3, R4 and R5 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: December 10, 2008
    Publication date: December 10, 2009
    Inventors: Mark Furber, Christopher Andrew Luckhurst, Hitesh Jayantilal Sanganee, Linda Anne Stein, Peter Alan Cage
  • Pyridopyrimidine Derivatives and Their Use as PDE4 Inhibitors
    Publication number: 20090233907
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE 4 mediated disease state.
    Type: Application
    Filed: March 20, 2007
    Publication date: September 17, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Rupert Austin, Roger Victor Bonnert, Simon Fraser Hunt, Grigorios Nikitidis, Hitesh Jayantilal Sanganee, Peter Olof Sjo, Dan Warner
  • Chemical Compounds 637
    Publication number: 20090124596
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    Type: Application
    Filed: January 10, 2008
    Publication date: May 14, 2009
    Inventors: Roger Victor Bonnert, Frank Burkamp, Rhona Jane Cox, Simon De Sousa, Mark Dickinson, Simon Fraser Hunt, Premji Meghani, Austen Pimm, Hitesh Jayantilal Sanganee
  • Chemical Compounds 636
    Publication number: 20080207650
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE 4 mediated disease state.
    Type: Application
    Filed: January 10, 2008
    Publication date: August 28, 2008
    Inventors: Roger Victor Bonnert, Hitesh Jayantilal Sanganee
  • Chiral auxiliaries
    Patent number: 5801249
    Abstract: This invention relates to novel compounds of general formula (I): ##STR1## wherein the two R.sup.1 groups are identical lower alkyl groups or together form a lower alkylene group; R.sup.2 and R.sup.3 are both different and are selected from hydrogen atoms or organic groups; X and X', which may be the same or different, are selected from O, S and NR, where R represents an organic group; and the asterisk denotes that the configurations of R.sup.2 and R.sup.3 are such that the compound (I) is in substantially enantiomerically pure 4R- or 4S-form. The compounds are useful chiral auxiliaries to which a wide range of, for example, acyl groups containing prochiral centers may be readily and reversibly coupled to the 3-position amino group.
    Type: Grant
    Filed: June 24, 1996
    Date of Patent: September 1, 1998
    Assignee: Oxford Asymmetry International plc
    Inventors: Stephen Graham Davies, Mario Eugenio Cosamino Polywka, Hitesh Jayantilal Sanganee